相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry
Patricia A. Cowper et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective
Radya Kumar et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Cost Analysis of Initial Treatment With Endovascular Revascularization, Open Surgery, or Primary Major Amputation in Patients With Peripheral Artery Disease
Linda Tang et al.
JOURNAL OF ENDOVASCULAR THERAPY (2018)
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Marc P. Bonaca et al.
CIRCULATION (2018)
Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia
Constantine E. Kosmas et al.
PATIENT PREFERENCE AND ADHERENCE (2018)
Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study
Dennis T. Ko et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe
Isabelle Ruel et al.
CLINICAL CHEMISTRY (2018)
Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations
Joseph V. Moxon et al.
ATHEROSCLEROSIS (2017)
Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care
Valeria Guglielmi et al.
ATHEROSCLEROSIS (2017)
PCSK9 inhibitor access barriersissues and recommendations: Improving the access process for patients, clinicians and payers
Seth J. Baum et al.
CLINICAL CARDIOLOGY (2017)
Assessment and validation of a novel angiographic scoring system for peripheral artery disease
D. R. Morris et al.
BRITISH JOURNAL OF SURGERY (2017)
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization
Birgitta Sigvant et al.
JOURNAL OF VASCULAR SURGERY (2016)
Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
Barbara H. Johnson et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2016)
The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)
M. L. Alva et al.
DIABETIC MEDICINE (2015)
Body mass index is inversely associated with mortality in patients with peripheral vascular disease
Jonathan Golledge et al.
ATHEROSCLEROSIS (2013)
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2013)
Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
Linda J. Cobiac et al.
BMC PUBLIC HEALTH (2012)
Everyone under statin?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
B. Mihaylova et al.
LANCET (2012)
Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations
Donald G. Pittman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Relation of Infra-Renal Abdominal Aortic Calcific Deposits and Cardiovascular Events in Patients With Peripheral Artery Disease
Adam Parr et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification
Jonathan Golledge et al.
ATHEROSCLEROSIS (2008)
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry
Patrice P. Cacoub et al.
ATHEROSCLEROSIS (2008)
Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
JOURNAL OF VASCULAR SURGERY (2007)
Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication
Jonathan Golledge et al.
JOURNAL OF VASCULAR SURGERY (2007)
Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations
TR Dillingham et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2005)
Brief comprehensive quality of life assessment after stroke - The assessment of quality of life instrument in the North East Melbourne Stroke Incidence Study (NEMESIS)
JW Sturm et al.
STROKE (2002)
One thousand health-related quality-of-life estimates
TO Tengs et al.
MEDICAL CARE (2000)
分享论文
